Anika Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $56.5M | $342.2M | $90.3M |
| Jun 2022 | $68.0M | $354.1M | $91.4M |
| Sep 2022 | $62.8M | $347.7M | $87.8M |
| Dec 2022 | $63.6M | $349.1M | $86.3M |
| Mar 2023 | $61.5M | $339.1M | $79.7M |
| Jun 2023 | $54.9M | $328.9M | $65.1M |
| Sep 2023 | $57.7M | $328.2M | $70.7M |
| Dec 2023 | $58.4M | $270.6M | $68.7M |
| Mar 2024 | $55.2M | $263.7M | $68.6M |
| Jun 2024 | $52.3M | $262.7M | $62.8M |
| Sep 2024 | $51.5M | $231.4M | $62.4M |
| Dec 2024 | $48.8M | $202.7M | $55.6M |
| Mar 2025 | $42.2M | $190.6M | $53.4M |
| Jun 2025 | $40.0M | $187.7M | $53.2M |
| Sep 2025 | $42.6M | $189.4M | $58.0M |
| Dec 2025 | $46.8M | $190.3M | $57.5M |
| Mar 2026 | $45.5M | $179.4M | $41.0M |
| Jun 2026 | $46.2M | $183.5M | $38.4M |